Shortage reports
Actual shortage:
257 (8%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
3059 (92%)
3327
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
411 (94%)
Reversed:
23 (5%)
436
485 (13%)
28 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2021-04-29 | 2021-08-24 | 138320 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-04-08 | 2021-05-27 | 137209 |
| TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136326 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2025-07-18 | 2025-10-23 | 263149 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2025-07-18 | 2025-11-13 | 263119 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118939 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-02-11 | 2021-02-25 | 133788 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-01-28 | 2021-02-25 | 132666 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176845 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2025-04-04 | 2025-05-08 | 254127 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2026-01-08 | 2026-03-12 | 275518 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2020-10-01 | 2020-11-12 | 125476 |
| TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2021-05-20 | 2021-05-27 | 139758 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2020-04-23 | 2020-07-23 | 113037 |
| TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107955 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2020-03-06 | 2020-07-23 | 107958 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2020-10-01 | 2020-10-08 | 125479 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2021-05-06 | 2021-05-27 | 138910 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223859 |
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140378 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CEFTRIAXONE SODIUM FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258691 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2021-02-12 | 2021-02-12 | 133886 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2025-05-27 | 2025-05-27 | 258359 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| COUGH SYRUP WITH CODEINE | 30MG 3.3MG 100MG | SYRUP SYRUP | Reversed | 2025-05-28 | 2025-06-03 | 258600 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 |